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Abstract:  We  investigate  a  immunoassay  biosensor  that  employs  a  Quartz  Crystal 
Microbalance  (QCM)  to  detect  the  specific  binding  reaction  of  the  (Human 
IgG1)-(Anti-Human  IgG1)  protein  pair  under  physiological  conditions.  In  addition  to 
experiments, a three dimensional time domain finite element method (FEM) was used to 
perform  simulations  for  the  biomolecular  binding  reaction  in  microfluidic  channels.  In 
particular, we discuss the unsteady convective diffusion in the transportation tube, which 
conveys the buffer solution containing the analyte molecules into the micro-channel where 
the QCM sensor lies. It is found that the distribution of the analyte concentration in the 
tube  is  strongly  affected  by  the  flow  field,  yielding  large  discrepancies  between  the 
simulations and experimental results. Our analysis shows that the conventional assumption 
of the analyte concentration in the inlet of the micro-channel being uniform and constant in 
time is inadequate. In addition, we also show that the commonly used procedure in kinetic 
analysis  for  estimating  binding  rate  constants  from  the  experimental  data  would 
underestimate these rate constants due to neglected diffusion processes from the inlet to the 
reaction  surface.  A  calibration  procedure  is  proposed  to  supplement  the  basic  kinetic 
analysis, thus yielding better consistency with experiments.   
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1. Introduction 
Efficient, accurate, and real-time monitoring of chronic diseases becomes more and more important 
for an aging society. Biosensors provide a quick and convenient technology for real-time surveillance 
in  health-care.  Biosensors  use  a  receptor  molecule  (the  ligand)  fixed  on  the  substrate  as  the 
bio-recognition layer. When the specific target molecules (the analyte) carried by the buffer solution 
flow over the reaction surface of a biosensor, a specific binding reaction occurs between the analyte 
molecules and the immobilized ligand molecules. A variety of physical mechanisms have been used in 
the transducer to record the specific binding and the subsequent real-time examination takes place by 
amplifying these signals [1]. With its superior characteristics of timely reaction and high sensitivity, 
the Quartz Crystal Microbalance (QCM) has recently become a commonly used biosensor. The QCM 
uses the indirect piezoelectric effect as a way of energy transformation to timely record the resonance 
frequency shifts with a tiny mass loading. In 1959, Sauerbrey [2]
 derived an equation (called Sauerbrey 
equation) to relate the change of the resonance frequency shift to the change of loaded mass on the 
crystal surface; namely,  ∆? = −2? 0∆𝑀/A 𝜇?𝜌?, where ∆f is the frequency shift, ∆M is the change 
of the load mass, f0 is the oscillating frequency of the quartz without loaded mass, μQ is the elastic 
modulus of the quartz, ρQ is the density of the quartz and A is the area of the electrode. Initially, QCM 
was  applied  as  a  gas-sensing  device  [3];  nowadays,  it  is  widely  used  in  research  on  bioimmune 
tests [4,5].
  
In this study, we use a Quartz Crystal Microbalance for detecting and tracking the specific binding 
reaction between Human IgG1 and Anti-Human IgG1. The mass change due to the formation of the 
(Human IgG1)-(Anti-Human IgG1) complex was recorded as the frequency shift versus time, which 
reflects the time evolution of the analyte concentration, the observable of most concern in a clinical 
diagnosis. Following the conventional procedure, a direct kinetic analysis based on the experimental 
data can be employed to estimate the binding rate constants, which are then used in the follow-up 
numerical studies of the binding reaction. We performed three dimensional finite element simulations 
of the binding reaction and compared our simulation results with the experimental data. Surprisingly, 
large discrepancies were found between the predicted and the experimental results. We indentified two 
major issues in the conventional analysis that could cause such inaccurate predictions. The first is the 
assumption of uniform and time-independent profile of the analyte concentration at the inlet of the 
micro-channel and the second is the inaccurate estimation of the binding rate constants. 
In  the  experiments,  we  used  a  transportation  tube  conveying  the  analyte  solution  to  the 
micro-channel. The cross-sectional concentration profile of the analyte at the end of the transportation 
tube,  which  is  also  the  inlet  to  the  micro-channel,  is  usually  assumed  to  be  uniform  and 
time-independent in the simulations. However, when the transportation tube is long, the deviation of 
the analyte concentration profile from uniformity across the tube section and time-independence is 
large [6-8]. In this work, we will show that the effect of such non-uniformity and time-dependence of Sensors 2010, 10                           
 
 
 
11500 
the analyte concentration profile is important for analyzing the binding behavior and should be taken 
into account during the simulation. 
Binding  rate  constants  are  usually  estimated  directly  from  a  basic  kinetic  analysis  of  the 
experimental data under the assumption [9] that the concentration of the analyte near the surface of the 
biosensor is the same as that in the bulk of the fluid. This assumption in fact leads only to an “apparent” 
binding  rate  constant  which  may  significantly  differ  from  the  “true”  one  because  the  diffusion 
processes from the inlet to the reaction surface cannot be neglected in a real situation. This can be 
cross-checked by an inverse calculation of the “apparent” binding rate constants from the simulated 
binding reaction curves, where the “true” rate constants are assumed to be known a priori. We show 
that the “apparent” rate constants underestimate the “true” ones. Therefore, an effective calibration 
procedure is proposed to amend the estimation of binding rate constants. The calibrated binding rate 
constants are then deemed to be the “true” binding rate constants and used to do further numerical 
simulations. Using this procedure, numerical predictions self-consistent with the experimental data are 
then found. 
This paper is organized as follows. In Section 2 we describe the detailed experimental procedures 
and the results.  The  governing equations  used  in  the  simulations are presented in  Section 3.  The 
detailed theoretical analysis is presented in Section 4. We compare and discuss the experimental and 
theoretical results in Section 5 and a brief summary is provided in Section 6. 
2. Experiment 
2.1. Materials and Methods 
Figure  1  shows  a  schematic  sketch  of  the  Quartz  Crystal  Microbalance  (Affinity-Sensor  New 
Technology, Taiwan) used in our experiments.   
Figure 1. Sketch of the 3D model of the QCM device. Part 1 is the transportation tube 
conveying the analyte solution into the micro-channel. Part 2 is the micro-channel with the 
reaction surface. 
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This QCM system consists of a flow-injection system and a QCM chip. The QCM chip is a 9-MHz 
quartz crystal placed as a sandwich between two gold electrodes and driven by an oscillator circuit to 
produce the oscillating frequency. The upper gold electrode is also used as the reaction surface. The 
flow-injection system uses a peristaltic pump to supply the QCM with a steady and continuous amount 
of  phosphate-buffered  saline  (PBS,  pH  7.2,  22  °C )  at  a  flow  rate  of  50  μL/min.  The  designated 
supplement of the analyte solution is continuously injected and stored in the sample loop, and placed 
between the buffer solutions via the injection valve, as shown in Figure 1. Then, the analyte solution 
can follow with the running buffer solution into the micro-channel where the QCM chip sits on the 
bottom side. 
2.2. Experiment Procedure 
In these immunoassay experiments, we used the QCM to monitor the real-time specific binding 
reaction of the immobilized ligand Human IgG1 (I5154, Sigma) and the Anti-Human IgG1 (I2513, 
Sigma)  analyte.  We  considered  three  groups  according  to  the  total  volume  of  Anti-Human  IgG1 
solution supplied during the individual experiments: 800, 500 and 100 μL, respectively. Each group 
also included four concentrations of Anti-Human IgG1 solution: 50, 25, 10 and 5 μg/mL. Before the 
experiment started, a self-assembled monolayer (SAM) of the linker molecules was formed on the 
QCM  chip  by  immersing  their  upper  gold  electrode  surface  in  16-mercaptohexadecanoic  acid 
(MHDA). The covalent bonded linkers served to efficiently immobilize the ligand bio-molecules on 
the reaction surface. There were four steps in the experiment process. First, a 2.5% glutaraldehyde 
solution in PBS was added into the QCM to activate the linker on the reaction surface. Following the 
activation a running PBS solution is used to rinse away the excess glutaraldehyde. The second step is 
to inject the ligand solution (Human IgG1 50 μg/mL in PBS) into the QCM to bind covalently with the 
linkers to form the immobilized layer on the reaction surface. Again the excess immobilization ligands 
were rinsed away with a running PBS solution. The third step is to add a glycine solution (1 M in PBS) 
to block the unbound linkers to prevent the occurrence of non-specific binding. After the blocking, the 
running PBS solution again rinses away the excess glycine. In the last step, the designated supplement 
(800, 500 or 100 μL) of Anti-Human IgG1 solution of various concentrations (50, 25, 10 or 5 μg/mL) 
was added into the QCM to react specifically with the immobilized Human IgG1.   
2.3. Experimental Results 
Figure 2 shows a typical result of the frequency shift versus time in a QCM experiment. Notice that 
for convenience and better visibility, we present only the magnitude of the frequency shift (drop) in the 
rest figures of this paper. Figures 3(A-C) present all of our experimental results of the binding curves 
for the Human IgG-Anti-Human IgG protein pair for the total volumes of Anti-Human IgG1 solution 
supplied during the individual experiments (800, 500 and 100 μL, respectively). Each subfigure in 
Figure 3 contains four curves corresponding to the four different concentrations of the Anti-Human 
IgG1 solution: 50, 25, 10 and 5 μg/mL, respectively. Comparing the curves presented in Figure 3, it is 
observed  that  the  behavior  of  binding  reaction  depends  not  only  on  the  concentration  of  the 
Anti-Human IgG1 solution but also on the amount of Anti-Human IgG1 solution supplied. Sensors 2010, 10                           
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Figure 2. A typical result of the QCM experiment. There are four steps in the experimental 
process, as described in the text. 
 
Figure  3.  The  (Human  IgG1)-(Anti-Human  IgG1)  protein  pair  binding  curves.  The 
supplemented volume of the Anti-Human IgG1 solution is: (A) 800 μL, (B) 500 μL and 
(C) 100 μL. For each case there are four concentrations of Anti-Human IgG1 solution (50, 
25, 10 and 5 μg/mL). The error bar at each time point is marked according to 4~5 replicates 
of the experimental raw data; namely picking the largest positive (negative) deviation value 
as our upper (lower) bound to the average value.   
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3. Simulation   
In this work the 3D simulation on the immunoassay in the QCM device is performed using the 
finite element analysis software, COMSOL Multiphysics [10], to simulate the experiments done in the 
above  section  for  the  (Human  IgG1)-(Anti-Human  IgG1)  binding  interactions.  The  equations 
governing the flow field, the concentration field and the biochemical reaction are described in this 
section. Detailed geometry, flow properties, binding constants and other conditions that are required 
for simulation are described in Section 4. 
3.1. The Flow Field 
In this work it is assumed that the fluid is incompressible so that: 
𝜕?
𝜕? +
𝜕?
𝜕? +
𝜕?
𝜕? = 0  (1) 
where u, v and w are the x, y and z velocity components, respectively. The equations of motion are: 
𝜌
𝜕?
𝜕? + 𝜌 ?
𝜕?
𝜕? + ?
𝜕?
𝜕? + ?
𝜕?
𝜕?  − 𝜂𝗻2? +
𝜕?
𝜕? = 0    
𝜌
𝜕?
𝜕? + 𝜌 ?
𝜕?
𝜕? + ?
𝜕?
𝜕? + ?
𝜕?
𝜕?  − 𝜂𝗻2? +
𝜕?
𝜕? = 0               (2) 
𝜌
𝜕?
𝜕? + 𝜌 ?
𝜕?
𝜕? + ?
𝜕?
𝜕? + ?
𝜕?
𝜕?   − 𝜂𝗻2? +
𝜕?
𝜕? = 0   
where η is the dynamic viscosity of the fluid and p is the pressure. In this work it is assumed that the 
density ρ and η viscosity of the modeled incompressible fluid are constant independent of temperature 
and concentration. 
3.2. The Concentration Field 
Transport of the analyte to and from the reaction surface is assumed to be described by Fick’s 
second law with convective terms: 
 
∂[?]
∂? + ?
∂[?]
∂? + ?
𝜕[?]
𝜕? + ?
𝜕[?]
𝜕? = ?(
𝜕2 ? 
𝜕?2 +
𝜕2 ? 
𝜕?2 +
𝜕2 ? 
𝜕?2 )  (3) 
where [A] is the concentration of the analyte and D is the diffusion coefficient of the analyte. 
3.3. The Reaction Surface 
The reaction between immobilized ligand and analyte is assumed to follow the first order Langmuir 
adsorption model [11,12]. During the reaction, the reaction complex [AB] increases as a function of 
time according to the reaction rate: 
 
∂[??]
∂? = ?? ? ???????   ?0  −  ??   − ??[??]  (4) 
where [A]surface is the concentration of the analyte at the reaction surface by mass-transport, [B0] is the 
surface concentration of the ligand on the reaction surface, and [AB] is the surface concentration of the 
reaction complex. 
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4. Simulation Detail and Kinetic Analysis 
As shown in Figure 1, our QCM device consists of a Part 1 and a Part 2. Part 1 is the tube loop for 
storing and transporting the sample solutions into the micro-channel. The lengths of the sample loop 
are 1.62, 1.10 and 0.20 m, corresponding to 800, 500 and 100 μL analyte supplements, respectively. 
Part 2 is the micro-channel where the QCM sensor is placed. The reaction surface is located at the 
bottom of the micro-channel. The dimensions of the 3D model are depicted in Figure 1. The analyte 
solution together with the buffer solution flows through the tube and passes through the left inlet to the 
right outlet of the micro-channel. The flow field in the tube is a fully developed laminar flow. The 
concentration profile of the analyte at the tube outlet (that is, inlet of the micro-channel) is strongly 
affected by the flow field in the tube. It is shown below that this concentration profile at the tube outlet 
is in fact not uniform and time-independent. This will in turn affect significantly the behavior of the 
binding reaction occurred on the QCM. Therefore, we shall first discuss the distribution of the analyte 
concentration at the tube outlet in Part 1, and then use the results obtained in Part 1 to simulate the 
reaction curves of the ligand and analyte in Part 2. 
4.1. The Flow Field   
The value of dynamic viscosity η is set as that of water, 6.96 ×  10
−3 Pa· s. Since the flows in the tube 
and micro-channel are in low Reynolds number condition, it is assumed that the flow is laminar. The 
average velocity of the parabolic profile is set to u = 1.68×  10
−3 m/s in the tube according to the 
experiment condition. The pressure at the micro-channel outlet is p = 0. 
4.2. The Concentration Field 
The diffusion coefficient of Anti-Human IgG1 is 5 ×  10
−11 m
2/s [13]. The initial concentrations of 
the analyte in the tube are chosen as [A] = 3.125 ×  10
−4 mol/m
3 (50 μg/mL), 1.5625 ×  10
−4 mol/m
3 
(25 μg/mL), 6.25 ×  10
−4 mol/m
3 (10 μg/mL) and 3.125 ×  10
−5 mol/m
3 (5 μg/mL). The initial surface 
concentrations [B0] are assumed as 7.8 ×  10
−8 mol/m
2 in the model of 800 μL, 5.6 ×  10
−8 mol/m
2 in the 
model of 500 μL and 5.2 ×  10
−8 mol/m
2 in the model of 100 μL from the experimental results. Since 
[B0] is not a constant in our experiments, the following normalized equation is used to represent the 
reaction between ligand and analyte:   
 
1
[??]
∂[??]
∂? = ka A surface  1 −
 ?? 
?0
  − ??
[??]
[?0]  (5) 
4.3. Kinetics of the Specific Binding 
The specific recognition of the analytes and immobilized ligands occurs on the reaction surface. 
The reaction kinetics can be described as a two-step process [14]. 
Mass-transport  process:  the  analyte  is  transported  by  diffusion  from  the  bulk  solution  toward  the 
reaction surface: 
[?]???? ⇆ [?]???????   (6) 
Chemical reaction process: the binding of the protein pair takes place: Sensors 2010, 10                           
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a
surface
d
k
A B AB
k
                (7) 
where [A]bluk, [A]surface, [B] and [AB] are the concentrations of the analyte in the bulk, the analyte at the 
reaction surface, the ligand on the reaction surface, and the analyte-ligand complex on the reaction 
surface, respectively. ka and kd are the association and dissociation rate constants, respectively. 
Conventionally, the association rate constant ka and dissociation rate constant kd of the specific 
protein pairs can be estimated from the experimental data by a basic kinetic analysis [9]. In this basic 
kinetic analysis, the mass-transport process is assumed so fast that the surface concentration [A]surface is 
the same as the bulk concentration[A]bluk, which is true for QCM working in an air environment. 
However,  such  an  assumption  is  not  valid  in  a  solution  environment  since  the  diffusion  of 
biomolecules, especially for the large molecules like Anti-Human IgG1, is slow in liquids. In addition, 
the flow speed in the micro-channel is usually also low, which limits the convective transport of the 
analyte.  Therefore,  the  conventional  analysis  actually  yields  the  “apparent”  association  and 
dissociation rate constants k
' 
a  and k
' 
d, but not the “true” ones. To remedy this deficiency in the basic 
kinetic analysis, in the following we propose a modified method, which calibrates the calculation of 
the conventional kinetic analysis, to recover the “true” reaction rate constants. 
4.3.1. Basic Kinetic Analysis and Calculation of Reaction Rate Constants 
The “apparent” reaction rate constants k
' 
a  and k
' 
d  are estimated by the method of Karlsson [14] 
under the assumption [A]surface ≈ [A]bluk, Equation (4) can then be rewritten as: 
∂[??]
∂? = ??[?]???????  [?0  − [??]] − ??[??] ≈ ??
′  ? ???? [ ?0  − [??]] − ??
′ [??]  (8) 
In general, the response R is equal to α[AB], where α is a proportional constant. When analyte 
solution  is  of  very  high  concentration,  all  the  binding  sites  of  the  ligand  are  occupied  and  the 
maximum response Rmax is equal to α[B0]. Thus, Equation (8) can be rewritten as: 
∂?
∂? = ??
′ ????? − (??
′ ? + ??
′ )?  (9) 
where the constant C is the concentration of the analyte in the bulk, that is [A]bluk. There are usually 
two methods to retrieve the rate constants. 
Method 1: 
According to the Equation (9), we can draw a plot of  ∂?/𝜕?  versus R and the plot will have a slope 
−ks equal to –(k
' 
aC + k
' 
d). Therefore, by calculating  ∂?/𝜕?  from the experimental data of R versus 
time t, we can plot the curve of  ∂?/𝜕?  versus R, whose slope is −ks for a given analyte concentration 
C. Then, the plot of −ks versus C can be drawn to obtain the slope k
' 
a  and the intercept k
' 
d. 
Method 2: 
We also can solve R from Equation (9) to yield: 
? =
??
′ ?????
??
′ ?+??
′ (1 − ?−(??
′ ?+??
′ )?)  (10) 
Then, we can obtain the apparent reaction rate constants k
' 
a  and k
' 
d  by curve fitting. Table 1 shows Sensors 2010, 10                           
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the estimated rate constants using the above two methods. We see that method 1 and method 2 yield 
similar k
' 
a  and k
' 
d  values.   
Table  1.  Reaction  rate  constants  of  the  (Human  IgG1)-(Anti-Human  IgG1)  binding 
reaction  in  the  PBS  solution  by  the  basic  kinetic  analysis  for  three  supplements  of 
Anti-Human IgG1 solution: (A) 800 μL, (B) 500 μL, and (C) 100 μL. Here K
' 
D  = k
' 
d/k
' 
a. 
(A)  k
' 
a  (M
−1 s
−1)  k
' 
d  (s
−1)  K
' 
D  (M) 
Method 1  1.27 ×  10
4  1.60 ×  10
−3  1.26 ×  10
−7 
Method 2  1.20 ×  10
4  1.60 ×  10
−3  1.33 ×  10
−7 
(B)  k
' 
a  (M
−1 s
−1)  k
' 
d  (s
−1)  K
' 
D  (M) 
Method 1  1.58 ×  10
4  2.80 ×  10
−3  1.77 ×  10
−7 
Method 2  1.69 ×  10
4  2.90 ×  10
−3  1.72 ×  10
−7 
(C)  k
' 
a  (M
−1 s
−1)  k
' 
d  (s
−1)  K
' 
D  (M) 
Method 1  1.89 ×  10
4  4.01 ×  10
−3  2.12 ×  10
−7 
Method 2  1.93 ×  10
4  4.06 ×  10
−3  2.10 ×  10
−7 
Next, we use the apparent k
' 
a  and k
' 
d  to perform a three dimensional finite element simulation. The 
simulation results are presented in Figure 4. By comparing to the experimental data shown in Figure 3, 
large errors are observed due to the inaccurate estimation of the binding rate constants.   
Figure 4. Simulated binding reaction curves. The supplement volume of the Anti-Human 
IgG1 solution is (A) 800 μL (B) 500 μL and (C) 100 μL. 
 
(A)                           (B)
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Therefore, we propose below a modified method to calibrate the calculation of the reaction rate 
constants in the conventional kinetic analysis. The calibrated rate constants will be used in the further 
3D simulation to verify their correctness.   
4.3.2. Modified Kinetic Analysis 
When the reaction reaches saturation, the time variation of the concentration of the analyte-ligand 
complex vanishes and [A]surface = [A]bluk Equation (8) can then be written as:   
 ?0  =  ?? ???  1 +
??/??
 ? ????
  ≈ [??]  
??? if [?]???? ≫
??
??
  (11) 
In the equation above, if we pick the concentration of the analyte solution to be high (designated 
[A]bluk = [Ã]bluk) that [Ã]bluk  ≫
??
??
, then Equation (11) yields:   
 ?0  =  ??    
??? when [?  ]???? ≫
??
??
  (12) 
where   ??    
???   is  the  corresponding  saturated  concentration  of  the  reaction  complex  when  the 
concentration of the analyte is very high such that [A]bluk  ≫
??
??
. Then from Equations (11) and (12), 
the equilibrium association constant KD can be computed as: 
𝐾? =
??
??
=  ? ????  
 ?0 
 ?? ???
− 1  =  ? ???? (
 ??    ???
 ?? ???
− 1)  (13) 
The experimental results shown in  Figure 3(A) are for the case of 800 μL Anti-Human IgG1 
solution, in which the reaction curves for the analyte concentrations [A] = 50 μg/mL and 50 μg/mL are 
saturated, and these two concentrations are deemed as [Ã]bluk and [A]bluk, respectively. So, we use the 
two corresponding maximum frequency shifts to calculate KD:   
𝐾? =  ? ????  
 ??    ???
 ?? ???
− 1  = 1.5625 × 10−7 ×  
221
209 − 1  = 8.97 × 10−9 (𝑀)  (14) 
Then, we perform the 3D simulation of binding reaction for thirty pairs of trial ka and kd, and 
compute the apparent association rate constant k
' 
a  by the basic kinetic analysis to set up a look-up 
Table 2.   
Table 2. The k
' 
a  table. 
ka  2 ×  10
4  5 ×  10
4  8 ×  10
4  11 ×  10
4  15 ×  10
4 
kd  0.9 ×  10
−4 
k
' 
a  4.68 ×  10
3  1.28 ×  10
4  1.87 ×  10
4  2.93 ×  10
4  4.76 ×  10
4 
kd  2 × 10
−4 
k
' 
a  4.30 ×  10
3  1.17 ×  10
4  1.67 ×  10
4  2.95 ×  10
4  4.14 ×  10
4 
kd  5 ×  10
−4 
k
' 
a  4.01 ×  10
3  1.14 ×  10
4  1.48 ×  10
4  2.84 ×  10
4  4.39 ×  10
4 
kd  8 ×  10
−4 
k
' 
a  4.26 ×  10
3
  9.80 ×  10
3
  1.38 ×  10
4
  2.78 ×  10
4
  4.17 ×  10
4
 
kd  11 ×  10
−4
 
k
' 
a  4.08 ×  10
3
  9.76 ×  10
3
  1.41 ×  10
4
  2.86 ×  10
4
  3.93 ×  10
4
 
kd  30 ×  10
−4
 
k
' 
a  3.78 ×  10
3  9.61 ×  10
3  1.33 ×  10
4  2.30 ×  10
4  3.39 ×  10
4 Sensors 2010, 10                           
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Then we can use this table and the apparent k
' 
a  calculated from the experimental data (see Table 1) 
by the basic kinetic analysis to access the “true” ka, which is roughly 8 ×  10
4 (M
−1 s
−1). Since the 
apparent dissociation rate constant k
' 
d  is very small, direct extrapolation from the basic kinetic analysis 
would  yield  large  error.  Instead,  we  can  compute  the  “true”  kd  by  kd  =  ka  ×   kD,  which  gives 
kd = 7.17 ×  10
−4 (s
−1). This value is about one fifth of the apparent k
' 
d  (see Table 1).   
5. Comparative Results 
The calibrated ka and kd can be found by the modified kinetic analysis in Section 4. Next, we use the 
calibrated ka and kd to simulate the IgG1-Anti-IgG1 binding reaction. First, the analyte concentration 
profiles at the tube outlet for 800 μL, 500 μL, and 100 μL analyte solutions, respectively, are shown in 
Figure  5  (A-C).  On  the  right  panel  of  Figure  5,  denoted  as  (D),  (E),  and  (F),  are  shown  the 
corresponding  curves  of  the  binding  reaction.  Each  of  the  subfigures  presents  the  four  curves 
corresponding  to  the  four  different  concentrations  of  Anti-Human  IgG1:  50,  25,  10 and  5 μg/mL, 
respectively. It is clearly seen that the analyte concentration profile in the tube is strongly affected by 
the laminar flow, and definitely is not uniform and constant. By decreasing the supplement of the 
analyte, the concentration of the analyte is apparently decayed when length of the tube is fixed. From 
Figures  5(D-F),  we  can  see  that  the  behavior  of  the  reaction  curves  depends  significantly  on  the 
supplement of the analyte. For example, consider the case of high concentration of Anti-Human IgG1 
solution, say 50 μg/mL. When the supplement of the Anti-Human IgG1 solution is sufficient, say 
800 μL, the reaction time required for saturation of forming Anti-Human IgG1/ Human IgG1 complex 
(and  is  the  frequency  shift)  is  600  s  as  shown  in  Figure  5(D),  which  falls  before  the  maximum 
concentration of Anti-Human IgG1 solution, which is about 45 μg/mL (a little less than 50 μg/mL), 
reached at the inlet of reaction chamber, say 780 s, as shown in Figure 5(A). Thus, saturation can be 
reached and maintained a period of time. In contrast, when the supplement of the Anti-Human IgG1 
solution is insufficient, say only 100 μL, Figures 5(C) and 5(F) show that the maximum concentration 
of Anti-Human IgG1 solution at the inlet of reaction chamber is only 12 μg/mL (much less 50 μg/mL), 
and the maximum frequency shift is 83% of that obtained when we have 800 μL the supplement of 
Anti-Human IgG1 solution. In addition, the maximum frequency shift cannot be maintained but starts 
to fall immediately. As for the case of low concentration of Anti-Human IgG1 solution, say 5 μg/mL, 
Figures  5(D)  and  5(F)  show  that  the  maximum  frequency  shift  for  100  μL  supplement  of  the 
Anti-Human  IgG1  solution  is  only  25%  of  that  for  800  μL  supplement  of  the  Anti-Human  IgG1 
solution.   
We compare the normalized reaction curves of experiment and simulation to verify the accuracy of 
the simulated model. These results are shown in Figures 6, 7 and 8 for supplements of 800, 500 and 
100 μL, respectively (Figures 7 and 8 may be found in the Supplementary material). We see that 
overall the simulations reproduce the main features of the experimental curves for a wide range of 
analyte  concentrations,  including  the  initial  slope  of  frequency,  reaction  time  to  saturation,  and 
maximum frequency shift (reduction), etc. 
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Figure 5. The distribution of the analyte concentration at the outlet of the tube, which is 
the inlet of the micro-channel, and the corresponding binding reaction curves. 
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Figure  6.  The  normalized  experimental  and  simulated  binding  reaction  curves  for  the 
800 μL supplement volume. Here the concentrations of the Anti-Human IgG1 solution are 
(A) 50 μg/mL, (B) 25 μg/mL, (C) 10 μg/mL, and (D) 5 μg/mL. 
 
6. Conclusions 
In this work, immunoassay experiments on Human IgG1 and the Anti-Human IgG1 were monitored 
with  a  QCM.  In  addition,  we  performed  3D  finite  element  analysis  to  simulate  the 
(Human IgG1)-(Anti-Human IgG1) binding reactions. We compare the results of the experiments and 
the simulations to verify the simulation model. Here we summarize our conclusions: 
(1) The  analyte  concentration  distribution  in  the  tube  is  strongly  affected  by  the  unsteady 
convective diffusion in the fully developed laminar flow. 
(2) The assumption of [A]surface = [A]bulk is not valid because of the effect of the slower mass 
transport  in  a  fluid  environment  than  that  in  the  air.  The  small  diffusion  coefficients  of 
Anti-Human IgG1, the high micro-channel height, and the slow flow rate are reasons for the 
limitation of mass transport. 
(3) The apparent association rate constant k
' 
a  and the apparent dissociation rate constant k
' 
d  of 
(Human IgG1)-(Anti-Human IgG1) pairs found by the basic kinetic analysis are not the real 
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constants  of  the  specific  binding  reaction  because  of  these  above-mentioned  reasons,  and 
needed to be corrected. 
(4) We propose a modified method to improve the basic kinetic analysis to obtain the calibrated ka 
and kd. Using the calibrated ka and kd to simulate reaction curves, we obtain the simulation 
results more consistent with the experiment results than those using the “apparent” k
' 
aand k
' 
d. 
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